Genetic Testing Market- Global Forecast To 2023

Genetic Testing Market- Global Forecast To 2023

ID: MRFR/HC/1477-CRR | June, 2017 | Region: Global | 140 pages | Cooked Research Reports

Global Genetic testing Market information, by Type (prescribed genetic testing, & DTC genetic testing), by Method (Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test), by Type of test (Diagnostic Test, Predictive Test, Family DNA Test, and others), by Indication (Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others) - Forecast to 2023


 


FIGURE 1                   GLOBAL GENETIC TESTING MARKET SHARE, BY TYPE (%)


 


Intended Audience



  • Genetic testing products manufacturers and suppliers

  • Genetic testing services providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Government authorities

  • Market Research and Consulting Service Providers

  • Potential Investors



Research Methodology:




 Sources: Directorate of Industries, Annual report, White paper, Company Presentation


 


Market Synopsis of Global Genetic testing Market:


Market Scenario:


Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment.


The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.



Segments:                                                                                                                                        


Global genetic testing market has been segmented on the basis of type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016. On the basis of method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016. On the basis of type of test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016. On the basis of indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.


Regional Analysis of Global Genetic Testing Market:                


Considering the global scenario of the market, due to continuous innovation, high awareness about the genetic testing and rapid adoption of new technology, Americas is largest market and was holding 46.3% market share of global Genetic testing in 2016. US is holding largest market share in North America region. European genetic testing market is expected to reach USD 2,553.10 million by 2023. On the other hand, due to increasing aging population and advances in the medical fields, the Asia-Pacific (APAC) is fastest growing market for Genetic testing and expected to grow at a CAGR of 10.1% during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness and lack of required infrastructure. 


Key Players for Global Genetic Testing Market:                                         


Some of the key players in this market are: Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Illumina Inc. (US), Myriad Genetics (US), PerkinElmer Inc. (US), QIAGEN N.V. (Germany), and Quest Diagnostics (US)


The report for global genetic testing market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5.1 Porters Five Forces

6.1 Prescribed Genetic Testing

6.2 Direct to consumer Genetic Testing

7.1 Molecular Genetic Test/ DNA Test

7.1.1 Direct Sequencing

7.1.2 PCR

7.1.3 Hybridization

7.1.4 Comparative genomic hybridization

7.1.5 DNA microarray analysis

7.1.6 Others

7.2 Chromosomal Genetic Test

7.2.1 FISH

7.2.2 Others

7.3 Biochemical Genetic Test

7.3.1 HPLC

7.3.2 Gas Chromatography/ Mass Spectrometry

7.3.3 Tandem Mass Spectrometry

8.1 Diagnostic Test

8.2 Predictive Test

8.3 Family DNA Test

8.4 Others

9.1 Cancer Testing

9.2 Neurogenetic Disorder Testing

9.3 Autoimmune Disorder Testing

9.4 Muscular dystrophies

9.5 Others

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 The US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.3 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia

10.4.1 China

10.4.2 India

10.4.3 Japan

10.4.4 South Korea

10.4.5 Rest of Asia

10.5 Pacific

10.6 Middle East and Africa

10.6.1 UAE

10.6.2 Saudi Arabia

10.6.3 Egypt

10.6.4 Rest of Middle East and Africa

10. Competitive landscape

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Overview

11.2.4 Key Development

11.2.5 SWOT Analysis

11.3 Illumina Inc.

11.3.1 Company Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.1.5 SWOT Analysis

11.4 Myriad Genetics

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Strategy:

11.4.5 SWOT Analysis

11.5 PerkinElmer Inc.

11.6.1 Company Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Overview

11.6.4 Key Development

11.6.5 SWOT Analysis

11.6 QIAGEN N.V.

11.6.1 Company Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Overview

11.6.4 Key Development

11.1.5 SWOT Analysis

11.7 Quest Diagnostics

11.7.1 Company Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Overview

11.7.4 Key Development

11.7.5 SWOT Analysis